Toshimichi Ueda
Director/Board Member bei SIGNPOST CORPORATION
Profil
Toshimichi Ueda is currently the Director & External Auditor at SanBio, Inc. He also holds the position of Director & Vice President at Hibiki Partners Co., Ltd.
since 2012 and Independent Outside Director at Signpost Corp.
(Tokyo) since 2018.
He completed his undergraduate degree from Keio University.
Aktive Positionen von Toshimichi Ueda
| Unternehmen | Position | Beginn |
|---|---|---|
| SIGNPOST CORPORATION | Director/Board Member | 30.05.2018 |
SanBio, Inc.
 SanBio, Inc. Medical/Nursing ServicesHealth Services SanBio, Inc. develops regenerative therapies for neurological disorders. The firm is focused on cell therapies for neurological disorders such as stroke, traumatic brain injury, eye disease, and Parkinson's disease. Its product pipeline includes SB623 and SB618. The company was founded by Keita Mori and Toru Kawanishi in 2001 and is headquartered in Mountain View, CA. | Director/Board Member | - |
| Hibiki Partners Co., Ltd. | Director/Board Member | 01.09.2012 |
Ausbildung von Toshimichi Ueda
| Keio University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SIGNPOST CORPORATION | Health Services |
| Private Unternehmen | 2 |
|---|---|
SanBio, Inc.
SanBio, Inc. Medical/Nursing ServicesHealth Services SanBio, Inc. develops regenerative therapies for neurological disorders. The firm is focused on cell therapies for neurological disorders such as stroke, traumatic brain injury, eye disease, and Parkinson's disease. Its product pipeline includes SB623 and SB618. The company was founded by Keita Mori and Toru Kawanishi in 2001 and is headquartered in Mountain View, CA. | Health Services |
| Hibiki Partners Co., Ltd. |
